Fig. 3

Biomarker levels in the subcohort. The results are based on linear mixed effect models, with log(biomarker) as the dependent variable and sex, age, BMI, kidney function, and time of the venipuncture since the index acute coronary syndrome (ACS) as explanatory variables. Top row: cTnI, cystatin C, and sST2 levels. sST2 levels differed statistically significant in the stabilized phase. Middle row: Galectin-3, vWF, and MPO levels. Levels of Galectin-3 were significantly higher in females in the stabilized phase. Bottom row: Total, HDL-, and LDL-cholesterol. Levels of HDL cholesterol were significantly higher in females in the stabilized phase.